editedbook
Publication: IIP Proceedings Year: 2022, Month: November Page No: 37-42, ISSN/ISBN: 978-93-95632-88-1, DOI/Link: https://rsquarel.org/assets/docupload/rsl20233B907555ED11982.pdf
RECOMBINANT DNA TECHNOLOGY IN DRUG DEVELOPMENT
Area/Stream: Biotechnology, Authors: Sumayya Shahzad, Keywords: Recombinant DNA technology; pharmaceutical proteins; monoclonal antibodies. Book Name /series: Futuristic Trends in Biotechnology, Volume 2, Book 27, Part 1, Chapter 4Publication: IIP Proceedings Year: 2022, Month: November Page No: 37-42, ISSN/ISBN: 978-93-95632-88-1, DOI/Link: https://rsquarel.org/assets/docupload/rsl20233B907555ED11982.pdf
Abstract:
Recombinant DNA technology (RDT) is a widely used technique and has multidisciplinary applications like improving healthcare, enhancing food resources and conferring resistance to adverse environmental effects in plants. The first biotechnology products to come on world market were industrial enzymes and pharmaceutical products. RDT is also utilized in diagnosis, prophylaxis and therapy of diseases and discovery of drugs. It is by virtue of this technology that many key proteins associated with healthcare and dietary purposes can be manufactured safely and affordably in sufficient quantity. However, production of proteins on large scale via RDT requires large amount of time, resources, labor but provide many prospects for economic growth. Now a days, a variety of recombinant pharmaceuticals are rapidly attaining commercial approvals. The biotechnology revolution has changed the research, development, production and marketing processes of drugs. But pharmaceutical production is still having certain methodological obstacles that need to be addressed for production of molecular medicine and this facet is being explored actively. Today, RDT has advanced tremendously with diverse applications, herein usage of RDT in drug development is described.
Cite this: Sumayya Shahzad,,"RECOMBINANT DNA TECHNOLOGY IN DRUG DEVELOPMENT", Futuristic Trends in Biotechnology, Volume 2, Book 27, Part 1, Chapter 4, November, 2022, 37-42, 978-93-95632-88-1, https://rsquarel.org/assets/docupload/rsl20233B907555ED11982.pdf
Views: 4169
Download File
News
